(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Omidria: Ophthalmic solution for irrigation (1-0.3%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PHENYLEPHRINE; KETOROLAC (fen il EF rin; kee toe ROLE ak) is a combination of 2 medicines used during eye surgery. Use of these medicines together helps to decrease pain after cataract and lens surgery.

In-Depth Information

Omidria 1%-0.3% Ophthalmic Solution for Irrigation

NDC: 622250600
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Miosis Inhibition, Ocular Pain

Storage Information
Store between 68 to 77 degrees F
Protect from light
Diluted medication is stable for 24 hours at 39 degrees F or for 4 hours at room temperature
Discard product if it contains particulate matter, is cloudy, or discolored
Omidria 1%-0.3% Ophthalmic Solution for Irrigation

Reported Side Effects for Omidria 1%-0.3% Ophthalmic Solution for Irrigation

Foreign Body Sensation Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Eye Irritation Incidence:
2.0%*
Severity: MILD
Onset: RAPID
High Eye Blood Pressure Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Eye Inflammation Incidence:
24.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Omidria

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5